BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35777416)

  • 1. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis.
    Hoeper MM; Dwivedi K; Pausch C; Lewis RA; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Park DH; Ghofrani HA; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Lange TJ; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Swift AJ; Thompson AAR; Elliot CA; Rosenkranz S; Condliffe R; Kiely DG; Halank M
    Lancet Respir Med; 2022 Oct; 10(10):937-948. PubMed ID: 35777416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry.
    Hoeper MM; Pausch C; Grünig E; Klose H; Staehler G; Huscher D; Pittrow D; Olsson KM; Vizza CD; Gall H; Benjamin N; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Rosenkranz S; Ewert R; Kaemmerer H; Lange TJ; Kabitz HJ; Skowasch D; Skride A; Jureviciene E; Paleviciute E; Miliauskas S; Claussen M; Behr J; Milger K; Halank M; Wilkens H; Wirtz H; Pfeuffer-Jovic E; Harbaum L; Scholtz W; Dumitrescu D; Bruch L; Coghlan G; Neurohr C; Tsangaris I; Gorenflo M; Scelsi L; Vonk-Noordegraaf A; Ulrich S; Held M
    J Heart Lung Transplant; 2020 Dec; 39(12):1435-1444. PubMed ID: 33082079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
    Vizza CD; Hoeper MM; Huscher D; Pittrow D; Benjamin N; Olsson KM; Ghofrani HA; Held M; Klose H; Lange T; Rosenkranz S; Dumitrescu D; Badagliacca R; Claussen M; Halank M; Vonk-Noordegraaf A; Skowasch D; Ewert R; Gibbs JSR; Delcroix M; Skride A; Coghlan G; Ulrich S; Opitz C; Kaemmerer H; Distler O; Grünig E
    Chest; 2021 Aug; 160(2):678-689. PubMed ID: 33581097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?
    Peacock AJ; Ling Y; Johnson MK; Kiely DG; Condliffe R; Elliot CA; Gibbs JSR; Howard LS; Pepke-Zaba J; Sheares KKK; Corris PA; Fisher AJ; Lordan JL; Gaine S; Coghlan JG; Wort SJ; Gatzoulis MA
    Pulm Circ; 2020; 10(1):2045894020914851. PubMed ID: 32284847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
    Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
    Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
    Rosenkranz S; Pausch C; Coghlan JG; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Delcroix M; Ghofrani HA; Ewert R; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Scelsi L; Neurohr C; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Lange TJ; Olsson KM; Hoeper MM; Opitz C
    J Heart Lung Transplant; 2023 Jan; 42(1):102-114. PubMed ID: 36333206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension.
    Lewis RA; Thompson AAR; Billings CG; Charalampopoulos A; Elliot CA; Hamilton N; Hill C; Hurdman J; Rajaram S; Sabroe I; Swift AJ; Kiely DG; Condliffe R
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32108045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
    J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses.
    Trip P; Nossent EJ; de Man FS; van den Berk IA; Boonstra A; Groepenhoff H; Leter EM; Westerhof N; Grünberg K; Bogaard HJ; Vonk-Noordegraaf A
    Eur Respir J; 2013 Dec; 42(6):1575-85. PubMed ID: 23949959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.
    Hoeper MM; Behr J; Held M; Grunig E; Vizza CD; Vonk-Noordegraaf A; Lange TJ; Claussen M; Grohé C; Klose H; Olsson KM; Zelniker T; Neurohr C; Distler O; Wirtz H; Opitz C; Huscher D; Pittrow D; Gibbs JS
    PLoS One; 2015; 10(12):e0141911. PubMed ID: 26630396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].
    Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV
    Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.
    Hoeper MM; Huscher D; Ghofrani HA; Delcroix M; Distler O; Schweiger C; Grunig E; Staehler G; Rosenkranz S; Halank M; Held M; Grohé C; Lange TJ; Behr J; Klose H; Wilkens H; Filusch A; Germann M; Ewert R; Seyfarth HJ; Olsson KM; Opitz CF; Gaine SP; Vizza CD; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Pittrow D
    Int J Cardiol; 2013 Sep; 168(2):871-80. PubMed ID: 23164592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low DLCO in idiopathic pulmonary arterial hypertension - clinical correlates and prognostic significance.
    Szturmowicz M; Kacprzak A; Franczuk M; Burakowska B; Kurzyna M; Fijałkowska A; Skoczylas A; Wesołowski S; Kuś J; Torbicki A
    Pneumonol Alergol Pol; 2016; 84(2):87-94. PubMed ID: 27238166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
    Rose L; Prins KW; Archer SL; Pritzker M; Weir EK; Misialek JR; Thenappan T
    J Heart Lung Transplant; 2019 Feb; 38(2):145-155. PubMed ID: 30391191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients.
    Radchenko GD; Zhyvylo IO; Titov EY; Sirenko YM
    Vasc Health Risk Manag; 2020; 16():29-39. PubMed ID: 32021226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis.
    Badagliacca R; Rischard F; Papa S; Kubba S; Vanderpool R; Yuan JX; Garcia JGN; Airhart S; Poscia R; Pezzuto B; Manzi G; Miotti C; Luongo F; Scoccia G; Sciomer S; Torre R; Fedele F; Vizza CD
    J Heart Lung Transplant; 2020 Apr; 39(4):310-320. PubMed ID: 32061507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical characteristics of systemic sclerosis-related pulmonary arterial hypertension].
    Wang H; Tian Z; Liu Y; Li M; Wang Q; Zeng X; Fang Q
    Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):390-3. PubMed ID: 25146407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era.
    Zhang R; Dai LZ; Xie WP; Yu ZX; Wu BX; Pan L; Yuan P; Jiang X; He J; Humbert M; Jing ZC
    Chest; 2011 Aug; 140(2):301-309. PubMed ID: 21330386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.